Oxaliplatin/5FU/LV in adjuvant colon cancer: Updated efficacy results of the MOSAIC trial, including survival, with a median follow-up of six years

Reviewer: Christopher Dolinsky, MD
Abramson Cancer Center of the University of Pennsylvania
Ultima Vez Modificado: 5 de junio del 2007

Translation for this article does not exist

Keywords

Click on any of these terms for more related articles

Blogs

Cancer and Hair Loss
by Bob Riter
February 11, 2016